MEDICATIONS: 2025 RELEASE
• AUTHOR(S)DONNA
GAUWITZ
TEST BANK
1
Reference
Ch. 1 — Definition of Terms / Pharmacology
Stem
A 72-year-old patient with chronic heart failure asks why the
provider changed from a brand-name ACE inhibitor to a generic
formulation. The medication order is for the generic name; the
eMAR shows the same dosing. The patient is anxious and asks
whether the generic will "work the same." As the bedside
nurse, what is the most appropriate next action?
,A. Tell the patient generics are always identical and provide
reassurance.
B. Explain bioequivalence, highlight the same active ingredient,
and answer patient questions.
C. Advise the patient to contact pharmacy to request the brand-
name drug.
D. Withhold the medication until the prescriber confirms brand-
name substitution.
Correct answer
B
Rationales
Correct (B): Explain that generic drugs contain the same active
ingredient and are considered bioequivalent; answering
questions reduces anxiety and supports adherence. This
clarifies a pharmacology term while aligning with patient
education standards and safe medication delivery.
A: Overstates certainty ("always identical") and omits
explanation—may leave patient distrustful and uninformed.
C: Requesting brand without assessing clinical need may delay
therapy and is not necessary if bioequivalence is acceptable.
D: Withholding medication without clinical indication risks
destabilizing the patient and violates safe medication
administration.
Teaching point
Explain bioequivalence and answer patient concerns to
promote adherence.
,Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
2
Reference
Ch. 1 — Drug Sources / Drug Uses
Stem
A nurse preparing a teaching plan for a patient discharged on an
herbal supplement added by the outpatient clinic asks you
whether it is considered a "drug" and what risks exist. The
patient is also on multiple prescription medications. What is the
best nursing action?
A. Tell the patient supplements are natural and harmless.
B. Document the supplement on the medication reconciliation
and assess for interactions.
C. Advise the patient to stop all prescribed medications while
taking the supplement.
D. Ignore the supplement because supplements are not
regulated like prescription drugs.
Correct answer
B
Rationales
Correct (B): Documenting supplements and assessing for
interactions prevents adverse drug events; demonstrates
understanding of drug sources and uses and supports safe,
, evidence-based practice.
A: Misleading and unsafe—natural does not equal harmless and
could interact with prescriptions.
C: Stopping prescribed meds risks harm and is not evidence-
based.
D: Ignoring the supplement endangers the patient by missing
potential interactions and disregards medication reconciliation
responsibilities.
Teaching point
Always reconcile and assess supplements for potential
interactions with prescribed medications.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
3
Reference
Ch. 1 — Drug Standards / Drug Legislation
Stem
During a medication safety inservice, a newly hired nurse asks
why controlled substances have special documentation
requirements. A patient requires PRN opioid doses recorded on
the eMAR. Which explanation should the nurse provide as the
most accurate legal rationale?
A. Controlled substances require extra documentation to track
inventory and prevent diversion.